FDA Investigator Ana S Cabrera
Ana S Cabrera has conducted inspections on 45 sites in 3 countries as of 18 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
45
Last Inspection Date:
18 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Japan,
Korea (Republic of)
FDA Investigators that have inspected at least one site in common with Ana S Cabrera:
Abby Lmozeke Baker,
Alberto A Viciedo,
Alexandra B Pitkin,
Allen Lou,
Althea A Williams,
Amy L Singer,
Amy M Cramer,
Amy Wyan Mai,
Ann Marie Montemurro,
Ann Marie Schofield,
Annemarie Bodnar,
Barbara A Burke,
Barbara J Maulfair,
Barbara L Rellahan, PhD,
Burnell M Henry,
Byungja E Marciante,
Cara M Minelli,
Celeta S Coves,
Christian D Lynch (CDL),
Christina N Maurino,
Christopher J Adams,
Comyar Shoghi,
Craig W Swanson,
Creighton T Tuzon,
Daniel J Grabicki,
Dave M Deroche,
Dawn L Wydner,
Deborah B Nixon,
Decarlos A Gomez,
Denise M Visco, Investigator,
Diane M Gubernot,
Donna D Gallien, MPH,
Doretha M Tonkins,
Doretha M Wilson,
Douglas C Kovacs,
Dr. Zhou Chen (nmi), MD PhD,
Edward O'shaughnessy,
Emily A Walters,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Esther A Ofori,
Eufemia G Gonzalez,
Frank J Marciniak,
Gail L Katz,
Gene D Arcy,
Gerald Mierle,
Gianine E Delade,
Gianine E Tompkins,
Helen B Ricalde,
Helen Verdel,
J David Doleski,
Jacqueline Mdiaz Albertini,
Jacqueline S Warner,
Jean M Kelahan,
Jeffrey J Ebersole,
Jennifer A Bazergui,
Jennifer L Custodio,
Jennifer Macmillan,
Joan A Loreng,
Joanne Pryzbylik,
Jonee J Mearns,
Joseph F Mcginnis, RPh,
Joy Rkozlowski Klena,
Juanita P Versace,
Julie D Bringger,
Justine Tomasso,
Karen E D'orazio,
Keith M Reilly,
Kelli F Dobilas,
Kelly Doremus,
Kelly I Anderson,
Kelly L Anderson,
Kerry A Kurdilla,
Kimberly M Bigler,
Kinh Q Mac,
Kip J Hanks,
Kristy A Zielny,
Laurissa S Flowers,
Laverne Puckett,
Lawrence H Howell,
LCDR Debra Emerson,
Lee Terry Moore,
Li Li,
Liatte Kreuger, PharmD,
Linda S Mattingly,
Lisa Harlan,
Lisa Mathew,
Luis A Carrion,
Maira P Brading,
Marion Michaelis,
Mariza M Jafary,
Marjorie D Schultz,
Martha T Olone,
Mary T Carden,
Matthew J Gretkierewicz,
Meihong Liu,
Melba Trivera Clavell,
Melissa A Freeman,
Melissa A Zuppe,
Melissa B Libby,
Michael Serrano,
Michelle L Johnson,
Mizanne E Lewis,
Nancy L Meade,
Nancy L Rolli,
Nerizza B Dalena,
Nerizza B Guerin,
Niraj R Mehta, PhD,
Nisha C Patel,
Omotunde O Osunsanmi,
Paul L Bellamy,
Paul M Chefor,
Paula A Trost,
Peter R Lenahan,
Prabhu P Raju,
Qiao Y Bobo,
Raymond W Brullo,
Regina T Brown,
Remache,
Richard D Manney,
Robert G Ruff,
Robert S Sweeton,
Roger J Adams,
Ronnie E Jackson,
Rose Ashley,
Sandra Kershaw,
Sarah Adella Fave,
Sarah Forney,
Schultz,
Shelley H Beausoleil,
Sherri J Liu,
Sheryl A Kochman,
Shirley H Isbill,
Sidney B Priesmeyer,
Simone E Pitts,
Sinai I Davis,
Stephanie T Durso,
Steven S Wahl,
Susan T Hadman,
Tania E Vizcaino,
Tania Y Hall,
Tara G Bizjak,
Teresita C Mercado,
Thomas J Arista,
Timothy P Lafave,
Valerie C Reed,
Vien Q Le,
Wayne J Meyer,
William R Chang,
Young M Yoon,
Yung W Chan,
Yvonne C Wilkes
Ana S Cabrera's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2000 | EIR | Howmedica Osteonics Corp - EIR, 2000-10-12 |
January, 2001 | FDA 483 | Torrance Memorial Medical Center - Form 483, 2001-01-25 |
April, 2001 | FDA 483 Response | Central Jersey Blood Center, Inc. - Form 483R, 2001-04-28 |
July, 2001 | EIR | Ortho-Clinical Diagnostics, Inc. - EIR, 2001-07-27 |
March, 2000 | FDA 483 | Becton Dickinson & Company - Form 483, 2000-03-31 |
March, 2000 | EIR | Becton Dickinson & Company - EIR, 2000-03-31 |
July, 2001 | FDA 483 | Ortho-Clinical Diagnostics, Inc. - Form 483, 2001-07-27 |
August, 2000 | FDA 483 | Musculoskeletal Transplant Foundation - Form 483, 2000-08-22 |
January, 2001 | FDA 483 Response | Torrance Memorial Medical Center - Form 483R, 2001-02-19 |
September, 2000 | EIR | Hoffmann La Roche Inc - EIR, 2000-09-27 |
January, 2001 | EIR | Torrance Memorial Medical Center - EIR, 2001-01-25 |
April, 2001 | FDA 483 | Central Jersey Blood Center, Inc. - Form 483, 2001-04-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more